ML18318A005: Difference between revisions

From kanterella
Jump to navigation Jump to search
(Created page by program invented by StriderTol)
 
(Created page by program invented by StriderTol)
 
(3 intermediate revisions by the same user not shown)
Line 17: Line 17:


=Text=
=Text=
{{#Wiki_filter:}}
{{#Wiki_filter:UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 November 14, 2018 The Honorable Buddy Carter United States House of Representatives Washington, DC 20515
 
==Dear Congressman Carter:==
 
This is to acknowledge receipt of your e-mail dated November 8, 2018, regarding training and experience requirements for different Categories of Radiopharmaceuticals; specifically, the geographic disparities and challenges in rural populations.
Please be assured that we are working on a response, and a reply will be forwarded to you as soon as possible.
Sincerely, Eugene Dacus, Director Office of Congressional Affairs}}

Latest revision as of 11:40, 20 October 2019

11-14-19 Acknowledgement Letter to Congressman Buddy Carter - Categories of Radiopharmaceuticals
ML18318A005
Person / Time
Issue date: 11/14/2018
From: Eugene Dacus
Office of Congressional Affairs
To: Carter B
US HR (House of Representatives)
Shared Package
ML18313A126 List:
References
LTR-18-0436
Download: ML18318A005 (1)


Text

UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 November 14, 2018 The Honorable Buddy Carter United States House of Representatives Washington, DC 20515

Dear Congressman Carter:

This is to acknowledge receipt of your e-mail dated November 8, 2018, regarding training and experience requirements for different Categories of Radiopharmaceuticals; specifically, the geographic disparities and challenges in rural populations.

Please be assured that we are working on a response, and a reply will be forwarded to you as soon as possible.

Sincerely, Eugene Dacus, Director Office of Congressional Affairs